Neo Ivy Capital Management

Position in ILMN — Illumina, Inc.

CIK 1727783 NEW YORK, NY

Position in ILMN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,703,792

-$123,240 QoQ

Shares Held

9,690

-49.6% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#367

of 932 holders

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Neo Ivy Capital Management holds $2,509,451 across 5 Diagnostics & Research names. ILMN ranks #1 (67.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ILMN	Illumina, Inc. This page	9,690	$1,703,792
2	VCYT	Veracyte, Inc.	6,822	$400,656
3	IQV	Iqvia Holdings Inc.	1,879	$363,060
4	DGX	Quest Diagnostics Inc	191	$40,482
5	A	Agilent Technologies, Inc.	11	$1,461

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,703,792	9,690	-49.6%	Shares	Sole	2026-08-14
2025-09-30	$1,827,032	19,238	+173.2%	Shares	Sole	2025-11-12
2025-03-31	$558,712	7,042	-27.9%	Shares	Sole	2025-05-06
2023-06-30	$1,831,402	9,768	+2329.9%	Shares	Sole	2023-08-16
2022-12-31	$81,284	402	-70.6%	Shares	Sole	2023-03-27
2022-06-30	$252,020	1,367	+415.8%	Shares	Sole	2022-08-16
2021-12-31	$100,816	265	-43.1%	Shares	Sole	2022-02-15
2021-03-31	$178,971	466	-31.9%	Shares	Sole	2021-10-07
2020-09-30	$211,410	684	—	Shares	Sole	2020-11-17
No filing history on record for this holder in this stock.